Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage i ovarian clear cell carcinoma
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 88 (3) , 394-399
- https://doi.org/10.1016/s0090-8258(02)00156-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Survival Probability in Ovarian Clear Cell AdenocarcinomaGynecologic Oncology, 1999
- Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III DiseaseGynecologic Oncology, 1996
- Histologic Correlates of Progression-Free Interval and Survival in Ovarian Clear Cell AdenocarcinomaGynecologic Oncology, 1993
- Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early StagesGynecologic Oncology, 1993
- Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapyGynecologic Oncology, 1992
- A phase II trial of adjuvant cisplatin and doxorubicin in Stage I epithelial ovarian cancerGynecologic Oncology, 1991
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.Journal of Clinical Oncology, 1991
- Ovarian Clear Cell CarcinomaInternational Journal of Gynecological Pathology, 1989
- Ovarian clear cell adenocarcinomaGynecologic Oncology, 1989
- Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinomaGynecologic Oncology, 1989